Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,240 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Electro-Acupuncture in Lung cancER : EALER Study

NCT07337096

Conditions
Accupuncture, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China
  • Jiangsu Provincial Hospital of Chinese Medicine Nanjing, Jiangsu, China
View Trial Details
Recruiting

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

NCT07564401

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +8 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • Novartis Investigative Site Singapore
View Trial Details
Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations
  • Stanford Medicine Cancer Center Stanford, California, United States
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 27 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

NCT07061535

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Disease Small Cell Lung Cancer, +11 more
Locations
  • Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China
  • Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science Jinan, Shandong, China
  • Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences Hangzhou, Zhejiang, China
  • First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775

Conditions
Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 40 locations
View Trial Details

Related conditions